This trial studied if a drug is safe & effective for people with depression that hasn't responded to other treatments.
- Major Depressive Disorder
1 Primary · 3 Secondary · Reporting Duration: Week 6
Side Effects for
3 Treatment Groups
1 mg COMP360 Psilocybin
1 of 3
25 mg COMP360 Psilocybin
1 of 3
10 mg COMP360 Psilocybin
1 of 3
568 Total Participants · 3 Treatment Groups
Primary Treatment: 25 mg COMP360 Psilocybin · No Placebo Group · Phase 3
Who is running the clinical trial?
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What site did they apply to?
|Innovative Clinical Research, Inc.||33.3%|
|Behavioral Clinical Research, Inc.||66.7%|
What portion of applicants met pre-screening criteria?
|Did not meet criteria||25.0%|
How many prior treatments have patients received?
Why did patients apply to this trial?
- "I’ve researched the use of psychedelics for years. I’ve always been drawn to unconventional medicine. After watching documentaries such as “How to Change You're Mind” I felt inspired to seek a cutting edge research study. I was diagnosed with Major Depressive Disorder over 20 years ago and have yet to find medication that helps. I have many coping skills like yoga, grounding, forest bathing, Gi Gong and deep breathing. I look forward to hearing back from you soon. Erin"
What questions have other patients asked about this trial?
- "Is screening done in person or via Zoom?"
Frequently Asked Questions
How many participants are currently taking part in this clinical research?
"Affirmative. Clinicaltrials.gov shows that, since its initial posting on February 1st 2023, this study is still actively seeking 568 individuals from 3 distinct medical centres to take part in the trial." - Anonymous Online Contributor
Is this experiment taking in more participants currently?
"Data accessible on clinicaltrials.gov reveals that this medical trial is still recruiting, having been posted February 1st 2023 and most recently updated January 25th 2023." - Anonymous Online Contributor
Has the FDA sanctioned 25 mg COMP360 Psilocybin for clinical application?
"There is prior clinical evidence verifying the safety of 25 mg COMP360 Psilocybin, thus affording it a score of 3." - Anonymous Online Contributor